BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 47,400 shares, an increase of 867.3% from the March 31st total of 4,900 shares. Based on an average trading volume of 158,300 shares, the short-interest ratio is currently 0.3 days.
BetterLife Pharma Price Performance
Shares of BetterLife Pharma stock traded up $0.00 during trading on Friday, hitting $0.05. 83 shares of the company's stock traded hands, compared to its average volume of 39,672. The firm's fifty day moving average price is $0.07 and its 200 day moving average price is $0.10. BetterLife Pharma has a twelve month low of $0.03 and a twelve month high of $0.19.
Get BetterLife Pharma alerts:BetterLife Pharma Company Profile
(Get Rating)
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Read More
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
- Mondelez International Pricing Power Takes It To New Highs
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
